What's the Problem?

Skin cancer statistics currently underestimate its true prevalence, with up to 3 million cases officially reported each year. This underestimation occurs due to the complexity of the diagnosis. In addition, the problem extends beyond skin cancer, as daily exposure to UV radiation leads to photoaging and other skin diseases. Current methods of UV protection lack efficient DNA repair, leading to the appearance of mutations that cause skin diseases. Current solutions include topical products with plankton extracts that claim to contain repairing photolyases. However, their efficacy, purity, and non-allergenicity are not empirically proven. These limitations demand a reliable solution that ensures mutation-free DNA repair and addresses the shortcomings of current offerings.

How are they Solving it?

Antarka is building a breakthrough biotech pipeline based on the most resilient bacteria from Antarctica. Our first technology is a high-performance DNA repair enzyme designed for the beauty industry. After years of research in extreme environments, we’ve identified the most powerful enzymes capable of repairing DNA damage in skin cells caused by solar UV radiation. Unlike conventional skincare products that address the visible consequences of DNA damage, Antarka targets the root cause—rapidly and effectively repairing 100% of UV-induced DNA lesions in minutes. This represents a paradigm shift in skin longevity and sun protection.

Go to their website

Next Startup

Alytix

Go back to portfolio